Infliximab for subacute manifestations of ulcerative colitis

NICE technology appraisal guidance [TA140] Published date:

Infliximab is not recommended for people with subacute, moderately to severely active ulcerative colitis. Subacute ulcerative colitis is defined as ulcerative colitis that would normally be managed without needing to stay in hospital overnight or having urgent surgery.

Get involved